FDA Approvals: Clarinex, Abilify, Isovorin

The FDA has approved desloratadine-pseudoephedrine sulfate extended-release tablets, (Clarinex-D 24-hour), a new indication for aripiprazole tablets and oral solution (Abilify), and two indications for the orphan drug levofolinic acid (Isovorin).Yael Waknine

Continue to FDA Approvals: Clarinex, Abilify, Isovorin on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz